Publications
23
Citations
397
Est. group size
—
Recurring co-author estimate
Active years
13
Publishing since 2013
- Intermittent versus continuous intravenous epoprostenol for the treatment of digital ischemia
Journal of Scleroderma and Related Disorders · 2024
- Pharmacotherapy considerations with finerenone in the treatment of chronic kidney disease associated with type 2 diabetes
American Journal of Health-System Pharmacy · 2023
- Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced Myocarditis
JACC CardioOncology · 2022
- Effect of Replacing Vendor QTc Alerts with a Custom QTc Risk Alert in Inpatients
Applied Clinical Informatics · 2022
- Abstract 12324: Biomarker Trends in Patients With Immune-Checkpoint Inhibitor Myocarditis
Circulation · 2022
- The Role of sGC Stimulators and Activators in Heart Failure With Reduced Ejection Fraction
Journal of Cardiovascular Pharmacology and Therapeutics · 2021
- Tacrolimus time in therapeutic range and long‐term outcomes in heart transplant recipients
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2021
- The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding
Journal of Thrombosis and Thrombolysis · 2020
- Overview of Riociguat and Its Role in the Treatment of Pulmonary Hypertension
Journal of Pharmacy Practice · 2020
- Pulmonary Arterial Hypertension: a Pharmacotherapeutic Update
Current Cardiology Reports · 2019
- Identifying Clinical Predictors of Switching From Direct Oral Anticoagulants to Warfarin
Clinical Medicine Insights Therapeutics · 2019
- Development of best practice recommendations for the safe use of pulmonary hypertension pharmacotherapies using a modified Delphi method
American Journal of Health-System Pharmacy · 2019
- Real-World Prevalence of Adverse Events After Initiating Sacubitril/Valsartan Compared With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Systolic Heart Failure
Journal of Cardiac Failure · 2019
- USE OF DUAL P-GLYCOPROTEIN AND MODERATE CYP3A4 INHIBITORS WITH RIVAROXABAN OR APIXABAN INCREASES BLEEDING
Journal of the American College of Cardiology · 2019
- Abstract 120: Effectiveness of a Pharmacist Population Health Intervention for Sacubitril/valsartan in Systolic Heart Failure
Circulation Cardiovascular Quality and Outcomes · 2019
- American Journal of Health-System Pharmacy×2
- Journal of Cardiac Failure×2
- Journal of the American College of Cardiology×2
- Current Cardiology Reports×1
- Journal of Thrombosis and Thrombolysis×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile